Top 20 of Heart Failure

Article title # Publications/# Citations

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

2000: AIAdler; CACull; DHadden; RRHolman; SEManley; DRMatthews; HANeil; IMStratton; RCTurner;

578

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

1999: ACastaigne; RCody; JPalensky; APerez; BPitt; WJRemme; JWittes; FZannad;

501

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

2005: American College of Cardiology; American College of Chest Physicians; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society; International Society for Heart and Lung Transplantation; WTAbraham; CDAdams; JLAnderson; ... EMAntman; MHChin; DPFaxon; AMFeldman; GSFrancis; VFuster; TGGaniats; JLHalperin; LFHiratzka; SAHunt; AKJacobs; MJessup; MAKonstam; DMMancini; KMichl; RNishimura; JAOates; JPOrnato; RLPage; PSRahko; BRiegel; MASilver; SCSmith; LWStevenson; CWYancy;

388

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

2000: DBurkhoff; YHisamatsu; TJayaraman; ARMarks; SOMarx; SReiken; NRosemblit;

375

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

1992: LBasta; EBraunwald; EJBrown; TECuddy; BRDavis; GCFlaker; EMGeltman; SGoldman; LAMoyé; MAPfeffer;

344

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

2005: Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators; JGCleland; JCDaubert; EErdmann; NFreemantle; DGras; LKappenberger; LTavazzi;

313

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

2005: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators; JAnderson; GHBardy; RBoineau; NClapp-Channing; LDDavidson-Ray; MDomanski; DPFishbein; ... ESFraulo; JHIp; GJohnson; KLLee; RMLuceri; DBMark; SEMcNulty; DLPacker; JEPoole; CTroutman;

310

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

2003: KRBailey; JCBurnett; SJJacobsen; DWMahoney; MMRedfield; RJRodeheffer;

303

Trends in prevalence and outcome of heart failure with preserved ejection fraction.

2006: RMHerges; DOHodge; SJJacobsen; TEOwan; MMRedfield; VLRoger;

297

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

2004: Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators; JBoehmer; MRBristow; PCarson; TDe Marco; DDeMets; DWDeVries; LDicarlo; ... AMFeldman; DAKass; SKrueger; LASaxon; BGWhite;

293

Improving primary care for patients with chronic illness: the chronic care model, Part 2.

2002: TBodenheimer; KGrumbach; EHWagner;

293

Diabetes and cardiovascular disease. The Framingham study.

1979: WBKannel; DLMcGee;

287

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators.

1991:

280

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

2003: Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators; RBittman; MGatlin; SHurley; JKleiman; FMartinez; JNeaton; BPitt; ... WRemme; BRoniker; FZannad;

269

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

1998: EJBenjamin; RBD'Agostino; WBKannel; DLevy; HSilbershatz; PAWolf;

262

Correction of anemia with epoetin alfa in chronic kidney disease.

2006: CHOIR Investigators; HBarnhart; DReddan; SSapp; AKSingh; LSzczech; KLTang; MWolfson;

260

Cardiac resynchronization in chronic heart failure.

2002: MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation; WTAbraham; ALClavell; DBDeLurgio; MEllestad; WGFisher; DLHayes; DZKocovic; ... ARLeon; ELoh; PMcAtee; JMessenger; MPacker; FPickering; ALSmith; CTruex; RJTrupp; JUnderwood;

254

The natural history of congestive heart failure: the Framingham study.

1971: WPCastelli; WBKannel; PAMcKee; PMMcNamara;

238

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

1996: MRBristow; JNCohn; WSColucci; MBFowler; EMGilbert; MPacker; NHShusterman;

233

Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.

2006: SEder; GGorkiewicz; GHaemmerle; GHeldmaier; GHoefler; MKlingenspor; DKratky; ALass; ... RMaier; CMeyer; JRozman; CTheussl; EFWagner; RZechner; RZimmermann;

232